3. DEFINITION
• Hypoglycemia is characterized by a reduction in plasma glucose
concentration (<70mg/dl) or to a level that may induce symptoms or signs
such as altered mental status and/or sympathetic nervous system
stimulation
7. CLINICAL FEATURES
• NEUROGLYCOPENIC MANIFESTATIONS :
Result of CNS glucose deprivation
Behavioural
change
Confusion
Fatigue
Seizure LOC
Cardiac
arrythmias
8. AUTONOMIC MANIFESTATIONS
• Result from perception of physiologic changes caused by CNS mediated
sympathoadrenal discharge triggered by hypoglycemia
9.
10.
11. DIFFERENTIAL DIAGNOSIS
• Stroke/ TIA
• Seizure disorder
• Traumatic head injury
• Brain tumor
• Narcolepsy
• Multiple sclerosis
• Psychosis/Hysteria/ Depression
• Sympathomimetic drug ingestion
• Altered sleep patterns and nightmares
12. TREATMENT
• Mild symptoms : Oral glucose
• With AMS : 50% Dextrose in water IV Bolus
Repeat after 15 minutes if hypoglycemia persists
When Blood glucose reaches 70mg/dl and regains consciousness
continue oral
• IV Dextrose infusion : If blood glucose normalized but patient remains
unconscious
• Check blood glucose every 30 minutes
• Failure to respond consider other causes
13. • Glucagon : 1mg SC/IM
Not recommended in Heavy alcohol users , Marathon runners,
Sulfonylureas induced hypoglycemia
• Sulfonylureas induced : Octreotide
• Refractory Sulfonylureas induced hypoglycemia : Diazoxide
15. DEFINITION
• Blood glucose concentration < 47mg/dl
• It also includes any glucose concentration low enough to cause signs or
symptoms of impaired brain function
• Severe hypoglycemia : <36mg/dl
• Recurrent hypoglycemia : 3 or more episodes
• Transient neonatal hypoglycemia : Within 48 hours of birth
18. TREATMENT
• Dextrose is the primary treatment
Dose : 0.5-1.0g/kg
• Newborn : 5mL/kg of 10% Dextrose
• Infants and children can receive 1 to 2mL/kg of 25% Dextrose
• Maintenance Dextrose : 6-8mg/kg/min with 10% Dextrose